Neurotez Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Crowdfunding

  • Financing Rounds
  • 8

Neurotez General Information

Description

Operator of a biopharmaceutical company intended to serve Alzheimer's patients characterized by hyperleptinemia. The company offers screening, identification, and characterization of treatments using biochemical, molecular, and cell biology in vivo models, enabling medical practitioners to improve the lives of their patients and serve the public responsibly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 111 Town Square Place
  • Suite 1201
  • Jersey City, NJ 07310
  • United States
+1 (908)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 111 Town Square Place
  • Suite 1201
  • Jersey City, NJ 07310
  • United States
+1 (908)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotez Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurotez‘s full profile, request access.

Request a free trial

Neurotez Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to serve Alzheimer's patients characterized by hyperleptinemia. The com
Drug Discovery
Jersey City, NJ
7 As of 2023

Boston, MA
 

Princeton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurotez Competitors (16)

One of Neurotez’s 16 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Bristol-Myers Squibb Corporation Princeton, NJ
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Xalud Therapeutics Venture Capital-Backed New York, NY
Maxona Pharmaceuticals Venture Capital-Backed Malvern, PA
You’re viewing 5 of 16 competitors. Get the full list »

Neurotez Patents

Neurotez Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014165043-A1 Fragments, mutants and chimeric fusion proteins of leptin for treating alzheimer's disease Inactive 13-Mar-2013
US-20140088000-A1 Leptin rescues neurons from alzheimer's disease related pathways triggered by lipid burden Inactive 27-Sep-2012
US-20130065825-A1 Compositions and methods for delaying senescence or cell death in neurons Inactive 14-Sep-2011
US-20120231457-A1 Compositions and methods for assessing a genetic risk of developing late-onset alzheimer's disease (load) Inactive 10-Mar-2011
AU-2009313562-A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta Active 04-Nov-2008 A61K38/22
To view Neurotez’s complete patent history, request access »

Neurotez Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotez Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurotez‘s full profile, request access.

Request a free trial

Neurotez FAQs

  • When was Neurotez founded?

    Neurotez was founded in 2005.

  • Where is Neurotez headquartered?

    Neurotez is headquartered in Jersey City, NJ.

  • What is the size of Neurotez?

    Neurotez has 7 total employees.

  • What industry is Neurotez in?

    Neurotez’s primary industry is Drug Discovery.

  • Is Neurotez a private or public company?

    Neurotez is a Private company.

  • What is Neurotez’s current revenue?

    The current revenue for Neurotez is .

  • How much funding has Neurotez raised over time?

    Neurotez has raised $150M.

  • Who are Neurotez’s investors?

    CRG Capital Partners has invested in Neurotez.

  • Who are Neurotez’s competitors?

    Centrexion Therapeutics, Bristol-Myers Squibb, Ability Pharma, Xalud Therapeutics, and Maxona Pharmaceuticals are some of the 16 competitors of Neurotez.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process